DLA Piper's FDA practice provides strategic counseling and advocacy for our pharmaceutical, medical device, dietary supplement, biologics, and diagnostics and clinical laboratory clients on a wide range of matters involving the FDA and other government agencies, from clinical development and marketing authorization strategies to post-marketing compliance. Our attorneys combine an understanding of agency practice, science, policy, and bioethics with practical strategies to meet business objectives and mitigate risk in an increasingly complex regulatory and enforcement environment.

We counsel clients in administrative and judicial enforcement actions and other proceedings involving the Food and Drug Administration (FDA), Federal Trade Commission (FTC), Drug Enforcement Administration (DEA), US Department of Justice (DOJ) and other federal and state agencies.